AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,312,002 | +50.2% | 350,355 | -6.2% | 0.00% | +50.0% |
| Q1 2024 | $9,527,025 | +723.3% | 373,316 | +191.9% | 0.00% | – |
| Q4 2023 | $1,157,242 | +31.4% | 127,872 | -7.3% | 0.00% | – |
| Q3 2023 | $880,440 | -15.0% | 138,000 | +47.8% | 0.00% | – |
| Q2 2023 | $1,035,219 | -59.6% | 93,347 | -44.0% | 0.00% | -100.0% |
| Q1 2023 | $2,560,119 | +67.4% | 166,783 | +142.0% | 0.00% | – |
| Q4 2022 | $1,529,357 | -36.5% | 68,921 | -53.3% | 0.00% | -100.0% |
| Q3 2022 | $2,410,000 | +373.5% | 147,576 | +321.2% | 0.00% | – |
| Q2 2022 | $509,000 | -8.8% | 35,036 | +15.9% | 0.00% | – |
| Q1 2022 | $558,000 | +59.0% | 30,237 | +104.4% | 0.00% | – |
| Q4 2021 | $351,000 | -0.3% | 14,795 | +3.7% | 0.00% | – |
| Q3 2021 | $352,000 | +26.2% | 14,262 | +26.3% | 0.00% | – |
| Q2 2021 | $279,000 | – | 11,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |